Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Renault

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|September 30, 2008
Molecular modelling of phthalates - PPARs interactionsNicolas Kambia, Nicolas Renault, Sebastien Dilly, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 30, 2017
Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A<sub>2A</sub> receptorRomain Duroux, Nicolas Renault, Joana Esteves Cuelho, et al.
British Journal of Pharmacology|June 18, 2016
Update on melatonin receptors: IUPHAR Review 20Ralf Jockers, Philippe Delagrange, Margarita L Dubocovich, et al.
International Journal of Molecular Sciences|November 11, 2022
Discovery of Compounds That Selectively Repress the Amyloidogenic Processing of the Amyloid Precursor Protein: Design, Synthesis and Pharmacological Evaluation of DiphenylpyrazolesChristophe Mesangeau, Pascal Carato, Nicolas Renault, et al.
European Journal of Medicinal Chemistry|April 1, 2016
Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agentsMohsine Driowya, Julien Leclercq, Valerie Verones, et al.
Journal of Medicinal Chemistry|January 17, 2014
Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular basesXavier Laurent, Benjamin Bertin, Nicolas Renault, et al.
Bioorganic & Medicinal Chemistry|March 22, 2018
New phenylaniline derivatives as modulators of amyloid protein precursor metabolismMarion Gay, Pascal Carato, Mathilde Coevoet, et al.
Chemical Biology & Drug Design|December 11, 2012
Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR featuresNicolas Renault, Xavier Laurent, Amaury Farce, et al.
Bioorganic & Medicinal Chemistry|May 14, 2018
Design and synthesis of 2,6-disubstituted-8-amino imidazo[1,2a]pyridines, a promising privileged structureRajaa Boulahjar, Angela Rincon Arias, Raphaël Bolteau, et al.
Journal of Medicinal Chemistry|January 21, 2012
Targeting peroxisome proliferator-activated receptors (PPARs): development of modulatorsCéline Pirat, Amaury Farce, Nicolas Lebègue, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Enzyme Inhibition and Medicinal Chemistry|September 30, 2008
Molecular modelling of phthalates - PPARs interactionsNicolas Kambia, Nicolas Renault, Sebastien Dilly, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 30, 2017
Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A<sub>2A</sub> receptorRomain Duroux, Nicolas Renault, Joana Esteves Cuelho, et al.
British Journal of Pharmacology|June 18, 2016
Update on melatonin receptors: IUPHAR Review 20Ralf Jockers, Philippe Delagrange, Margarita L Dubocovich, et al.
International Journal of Molecular Sciences|November 11, 2022
Discovery of Compounds That Selectively Repress the Amyloidogenic Processing of the Amyloid Precursor Protein: Design, Synthesis and Pharmacological Evaluation of DiphenylpyrazolesChristophe Mesangeau, Pascal Carato, Nicolas Renault, et al.
European Journal of Medicinal Chemistry|April 1, 2016
Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agentsMohsine Driowya, Julien Leclercq, Valerie Verones, et al.
Journal of Medicinal Chemistry|January 17, 2014
Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular basesXavier Laurent, Benjamin Bertin, Nicolas Renault, et al.
Bioorganic & Medicinal Chemistry|March 22, 2018
New phenylaniline derivatives as modulators of amyloid protein precursor metabolismMarion Gay, Pascal Carato, Mathilde Coevoet, et al.
Chemical Biology & Drug Design|December 11, 2012
Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR featuresNicolas Renault, Xavier Laurent, Amaury Farce, et al.
Bioorganic & Medicinal Chemistry|May 14, 2018
Design and synthesis of 2,6-disubstituted-8-amino imidazo[1,2a]pyridines, a promising privileged structureRajaa Boulahjar, Angela Rincon Arias, Raphaël Bolteau, et al.
Journal of Medicinal Chemistry|January 21, 2012
Targeting peroxisome proliferator-activated receptors (PPARs): development of modulatorsCéline Pirat, Amaury Farce, Nicolas Lebègue, et al.
Pageof 5